Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag for thrombocytopenia in chronic liver disease undergoing elective procedures
jRCT2080222694Phase 3
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Thrombocytopenia and chronic liver disease (CLD) comparing Avatrombopag arm with Placebo arm (2 arms).
02
Drugs
avatrombopag
03
Conditions
Thrombocytopeniachronic liver disease (CLD)
Beyond the preview
Go deeper on jRCT2080222694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222694.